Actuate Therapeutics ACTU
NASDAQ ACTU
$0.33 +0.03 (+11.22%)
As of: Nov 11, 2026 · 10:23 AM EST

Actuate Therapeutics (ACTU) Price to Book (2024 - 2026)

Updated

Actuate Therapeutics' (ACTU) Price to Book was 37.14 for Q2 2026.

Analysis

Actuate Therapeutics (ACTU) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Price to Book at Actuate Therapeutics was 17.95, down 97.2% from FY2024.

  • By year, Price to Book came in at 639.69 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Price to Book since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Actuate Therapeutics 7.20 Mn -35.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.14
Mar 31, 2026 17.17
Dec 31, 2025 17.95
Sep 30, 2025 14.22
Dec 31, 2024 639.69
Sep 30, 2024 14.98
API Access

Actuate Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=ACTU&period=max&api_key=YOUR_API_KEY